$Viracta Therapeutics (VIRX.US)$ Oppenheimer analyst Hartaj ...
$Viracta Therapeutics(VIRX.US$ Oppenheimer analyst Hartaj Singh maintains Viracta Therapeutics (NASDAQ:VIRX) with a Outperform and maintains $13 price target.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment